We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

122 hedge funds and large institutions have $203M invested in Rigel Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,662% more call options, than puts

Call options by funds: $1.28M | Put options by funds: $34K

264% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 11

126% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 19

31% more funds holding

Funds holding: 93 → 122 (+29)

5% more capital invested

Capital invested by funds: $193M → $203M (+$10.4M)

0.94% more ownership

Funds ownership: 67.65% → 68.59% (+0.94%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
122
Holders Change
+29
Holders Change %
+31.18%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
40
Increased
43
Reduced
19
Closed
11
Calls
$1.28M
Puts
$34K
Net Calls
+$1.25M
Net Calls Change
+$5.64M

Top Buyers

1
SCM
Soleus Capital Management
Connecticut
+$3.76M
2
BlackRock
BlackRock
New York
+$3.58M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.03M
4
JP Morgan Chase
JP Morgan Chase
New York
+$2.96M
5
HIM
Hillsdale Investment Management
Ontario, Canada
+$2.91M

Top Sellers

1
Invesco
Invesco
Georgia
-$17M
2
AC
Armistice Capital
New York
-$7.36M
3
SCM
Stonepine Capital Management
Oregon
-$5M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$2.54M
5
N
Nuveen
North Carolina
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
26
State of Wisconsin Investment Board
Wisconsin
$1.22M +$836K +43,591 +151%
Millennium Management
27
Millennium Management
New York
$1.18M +$1.35M +70,426 New
HF
28
HRT Financial
New York
$1.15M +$1.31M +68,191 New
Squarepoint
29
Squarepoint
New York
$1.07M +$348K +18,159 +40%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$1.06M +$468K +24,400 +63%
BCM
31
Bridgeway Capital Management
Texas
$1.06M -$32K -1,670 -3%
Jane Street
32
Jane Street
New York
$1.05M +$708K +36,939 +144%
Two Sigma Investments
33
Two Sigma Investments
New York
$1.02M +$1.17M +60,913 New
GC
34
Globeflex Capital
California
$880K +$827K +43,095 +468%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$844K +$89.6K +4,672 +10%
TI
36
Trexquant Investment
Connecticut
$743K +$847K +44,171 New
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$683K +$480K +25,012 +161%
Universal-Beteiligungs- und Servicegesellschaft
38
Universal-Beteiligungs- und Servicegesellschaft
Germany
$676K +$771K +40,200 New
SBH
39
Segall Bryant & Hamill
Illinois
$610K +$695K +36,259 New
Wellington Management Group
40
Wellington Management Group
Massachusetts
$588K +$671K +34,983 New
Bank of America
41
Bank of America
North Carolina
$541K +$67.5K +3,520 +12%
AllianceBernstein
42
AllianceBernstein
Tennessee
$529K – – –
Barclays
43
Barclays
United Kingdom
$527K +$76.5K +3,991 +15%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$520K +$190K +9,893 +47%
Lazard Asset Management
45
Lazard Asset Management
New York
$518K +$208K +10,828 +54%
JF
46
Jump Financial
Illinois
$505K +$283K +14,750 +96%
Citadel Advisors
47
Citadel Advisors
Florida
$478K +$545K +28,411 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$423K +$28.5K +1,485 +6%
SO
49
STRS Ohio
Ohio
$414K – – –
CFM
50
Catalyst Funds Management
Australia
$399K +$403K +21,000 +778%
1
2
3 4 5

RIGL Hedge Fund Activity: Q4 2024 in Review

122 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2024, worth a combined $203M — up 5.4% from $193M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new RIGL positions and 11 closed out — a net gain of 29 holders — while 43 added to existing stakes and 19 trimmed.

The largest buyer was Soleus Capital Management, adding an estimated $3.76M. The largest seller was Invesco, exiting entirely with an estimated $17M sold.

  • 122 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2024, up from 93 in Q3 2024.
  • Funds reported $203M of Rigel Pharmaceuticals stock for Q4 2024, up 5.4% quarter-over-quarter.
  • 40 funds opened new Rigel Pharmaceuticals positions in Q4 2024 and 11 closed out, a net change of +29 holders.
  • The largest Rigel Pharmaceuticals buyer in Q4 2024 was Soleus Capital Management, an estimated $3.76M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2024 was Invesco, an estimated $17M sold.

Based on aggregated 13F filings for Q4 2024.